Piper Sandler Maintains Neutral on Dentsply Sirona, Lowers Price Target to $12
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsPrice Target
Piper Sandler analyst Jason Bednar maintains Dentsply Sirona (NASDAQ:XRAY) with a Neutral and lowers the price target from $14 to $12.
Piper Sandler analyst Jason Bednar maintains Dentsply Sirona (NASDAQ:XRAY) with a Neutral and lowers the price target from $14 to $12.